Comparison of the physical and chemical stability of niclosamide crystal forms in aqueous versus nonaqueous suspensions

Drug Development and Industrial Pharmacy

Volumn 30, Issue 6, 2004, Pages 581-592

  De Villiers, Melgardt M ^a   Mahlatji, Mabatane D ^b   Van Tonder, Elsa C ^c   Malan, Sarel F ^c   Lötter, Antonie P ^c   Liebenberg, Wilna ^c  

^a UNIVERSITY OF LOUISIANA AT MONROE   (United States)

^b Medicines Control Council   (South Africa)

^c NORTH WEST UNIVERSITY   (South Africa)

Author keywords

Aqueous vehicle; Niclosamide; Nonaqueous vehicle; Polymorphs; Suspensions

Indexed keywords

DIMETHYL SULFOXIDE; METHANOL; N,N DIMETHYLFORMAMIDE; NICLOSAMIDE;

AQUEOUS SOLUTION; ARTICLE; CRYSTAL STRUCTURE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG STABILITY; MOISTURE; MOLECULAR STABILITY; SCANNING ELECTRON MICROSCOPY; SUSPENSION; TEMPERATURE DEPENDENCE; X RAY POWDER DIFFRACTION;

ANTINEMATODAL AGENTS; CHEMISTRY, PHYSICAL; CRYSTALLIZATION; DRUG STABILITY; NICLOSAMIDE; SOLUBILITY; SUSPENSIONS; TABLETS; TEMPERATURE; WATER;

EID: 3142661784     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.1081/DDC-120037489     Document Type: Article

References (18)

1. Niclosamide Technical. Full Specification WHO/SMT/6.R1; World Health Organization Revised: Geneva, 10 December 1999; 13 pp.
2. Van Tonder, E.C. Preparation and Characterisation of Niclosamide Crystal Modifications, Ph.D. Thesis; Potchefstroom University for CHE: South Africa, 1996; 261 pp.
3. Van Tonder, E.C.; Lötter, A.P.; De Villiers, M.M.; Caira, M.R.; Liebenberg, W. Correlation between hydrate formation and the physical instability of suspensions prepared with different niclosamide crystal forms. Pharm. Ind. 1998, 60, 722-725.
4. Van Tonder, E.C.; Maleka, T.S.P.; Liebenberg, W.; Song, M.; Wurster, D.-E.; De Villiers, M.M. Preparation and physicochemical properties of niclosamide anhydrate and two monohydrates. Int. J. Pharm. 2004, 269, 417-432.
5. VanTonder, E.C.; Mahlatji, M.D.; Malan, S.F.; Liebenberg, W.; Caira, M.R.; Song, M.; DeVilliers, M.M. Preparation and physicochemical characterization of five niclosamide solvates and one hemisolvate. AAPS PharmSciTech 2004, 5 (1), in press. http://www.pharmscitech.org.
6. Caira, M.R.; Van Tonder, E.C.; De Villiers, M.M.; Lötter, A.P. Diverse modes of solvent inclusion in crystalline pseudopolymorphs of the anthelmintic drug niclosamide. J. Incl. Phenom. Mol. Rec. Chem. 1998, 31, 1-16.
7. Khalil, S.A.; Motawi, M.M.; Ebian, A.R.; Moustafa, M.A. Effect of additives on the kinetics of interconversion of sulphamethoxydiazine crystal forms. J. Pharm. Pharmacol. 1973, 25, 13-20.
8. Khalil, S.A.; Motawi, M.M.; Ebian, A.R.; Moustafa, M.A. Succinylsulfathiazole crystal forms: crystal growth studies. J. Pharm. Sci. 1975, 64, 1481-1489.
9. Martin, A. Coarse dispersion. In Physical Pharmacy; Lea & Febiger: Philadelphia, 1993; 477-511.
10. Pearson, J.T.; Varney, G. Crystal studies involving phase transitions in aqueous drug suspensions. J. Pharm. Pharmacol. 1969, 21, 60s-90s.
11. Abdallah, O.; Graf, E.; Beyer, C. The physical instability of sulfamethoxazole suspensions. Pharm. Ind. 1982, 44, 1071-1074.
12. Haleblian, J.K.; Mccrone, W. Pharmaceutical applications of polymorphism. J. Pharm. Sci. 1969, 58, 911-929.
13. Zografi, G.; Schott, H.; Swarbrick, J. Dispersed systems. In Remington's Pharmaceutical Sciences, 18th Ed.; Genarro, A.R., Ed.; Mack: Pennsylvania, 1990; 257-309.
14. Schultz, D.P.; Hardman, P.D. Hydrolysis and photolysis of the lampricide 2′,5-dichlorosalicylanilide (Bayer 73). Invest. Fish Control 1978, 3, 83-85.
15. Wollmann, H.; Zimmermann, M. Stability testing of niclosamide and vanillin. Part 20. Stability of pharmaceuticals. Zentralblat Fuer Pharmazie. Pharmakotherapie und Laboratoriumsdiagnostik 1983, 126, 571-579.
16. Bergisadi, N.; Sarigul, D. Determination of niclosamide and its stability in simulated gastric and intestinal media. Acta Pharm. Turc. 1986, 28 (2), 51-54.
17. Stephenson, G.A.; Groleau, E.G.; Kleeman, R.L.; Xu, W.; Rigsbee, R.D. Formation of isomorphic desolvates: creating a molecular vacuum. J. Pharm. Sci. 1998, 87, 536-542.
18. United States Pharmacopoeia. USP 25: NF 20; United States Pharmacopoeial Convention: Rockville, MD, 2002; 2569 pp.